Your browser doesn't support javascript.
loading
Myo5b knockout mice as a model of microvillus inclusion disease.
Cartón-García, Fernando; Overeem, Arend W; Nieto, Rocio; Bazzocco, Sarah; Dopeso, Higinio; Macaya, Irati; Bilic, Josipa; Landolfi, Stefania; Hernandez-Losa, Javier; Schwartz, Simo; Ramon y Cajal, Santiago; van Ijzendoorn, Sven C D; Arango, Diego.
Afiliação
  • Cartón-García F; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
  • Overeem AW; Department of Cell Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Nieto R; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
  • Bazzocco S; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
  • Dopeso H; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
  • Macaya I; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
  • Bilic J; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
  • Landolfi S; Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain.
  • Hernandez-Losa J; Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain.
  • Schwartz S; Group of Drug Delivery and Targeting, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Ramon y Cajal S; Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain.
  • van Ijzendoorn SC; Department of Cell Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Arango D; 1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Zaragoza, Spain.
Sci Rep ; 5: 12312, 2015 Jul 23.
Article em En | MEDLINE | ID: mdl-26201991

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Miosina Tipo V / Diarreia / Modelos Animais de Doenças / Síndromes de Malabsorção / Microvilosidades / Mucolipidoses Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Miosina Tipo V / Diarreia / Modelos Animais de Doenças / Síndromes de Malabsorção / Microvilosidades / Mucolipidoses Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Espanha
...